HomeLJUIF • OTCMKTS
add
SSY Group Ltd
Previous close
$0.40
Year range
$0.40 - $0.43
Market cap
7.13B HKD
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (HKD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.01B | -17.09% |
Operating expense | 291.23M | 3.68% |
Net income | 93.56M | -50.15% |
Net profit margin | 9.27 | -39.88% |
Earnings per share | — | — |
EBITDA | 240.10M | -33.47% |
Effective tax rate | 9.94% | — |
Balance Sheet
Total assets
Total liabilities
| (HKD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.74B | 23.43% |
Total assets | 12.81B | 1.66% |
Total liabilities | 5.19B | 2.45% |
Total equity | 7.62B | — |
Shares outstanding | 2.92B | — |
Price to book | 0.16 | — |
Return on assets | 2.52% | — |
Return on capital | 2.77% | — |
Cash Flow
Net change in cash
| (HKD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 93.56M | -50.15% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Lijun International Pharmaceutical (Holding) Co., Limited is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments: Wikipedia
Founded
1999
Website
Employees
5,500
